Does TREPROSTINIL Cause Infusion site erythema? 2,990 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,990 reports of Infusion site erythema have been filed in association with TREPROSTINIL (TYVASO). This represents 3.3% of all adverse event reports for TREPROSTINIL.
2,990
Reports of Infusion site erythema with TREPROSTINIL
3.3%
of all TREPROSTINIL reports
65
Deaths
719
Hospitalizations
How Dangerous Is Infusion site erythema From TREPROSTINIL?
Of the 2,990 reports, 65 (2.2%) resulted in death, 719 (24.0%) required hospitalization, and 30 (1.0%) were considered life-threatening.
Is Infusion site erythema Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 2,990 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Infusion site erythema?
HUMAN IMMUNOGLOBULIN G (1,850)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (312)
AMBRISENTAN (308)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (213)
FOSCARBIDOPA\FOSLEVODOPA (157)
MACITENTAN (147)
EPOPROSTENOL (90)
RIOCIGUAT (80)
LECITHIN\POLOXAMER 407 (70)
INFLIXIMAB-DYYB (62)
Which TREPROSTINIL Alternatives Have Lower Infusion site erythema Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE